Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma

Zahonero, C.; Aguilera, P.; Ramirez-Castillejo, C.; Pajares, M.; Bolos, M. V.; Cantero, D.; Perez-Nunez, A.; Hernandez-Lain, A.; Sanchez-Gomez, P.; Sepulveda, J. M.

期刊名称Molecular Cancer Therapeutics
作者Zahonero, C.; Aguilera, P.; Ramirez-Castillejo, C.; Pajares, M.; Bolos, M. V.; Cantero, D.; Perez-Nunez, A.; Hernandez-Lain, A.; Sanchez-Gomez, P.; Sepulveda, J. M.
卷第14卷
期第7期
印刷ISSN1535-7163
电子ISSN1538-8514
文件大小1406.17KB
发表时间2015-07-01
DOI10.1158/1535-7163.MCT-14-0736
页码1548-1558

发现好书期刊，享受阅读乐趣

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma